Atul Ltd appoints Vashi and Desai to senior management

1 min read     Updated on 20 Jul 2026, 06:34 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Atul Ltd has restructured its senior management team with the appointment of Dhaval Vashi as Senior Vice President of Pharmaceuticals and Vinay Desai as Executive Vice President of Technology and Manufacturing, effective July 18, 2026. These appointments follow the retirement of Dr Prabhakar Chebiyyam, President of Pharmaceuticals. Both new appointees have been associated with the company since December 2022.

powered bylight_fuzz_icon
46098249

*this image is generated using AI for illustrative purposes only.

Atul Ltd has restructured its senior management team with the appointment of Dhaval Vashi and Vinay Desai to key leadership roles effective July 18, 2026. The changes follow the retirement of Dr Prabhakar Chebiyyam from the position of President, Pharmaceuticals. The company communicated these personnel shifts to the stock exchanges pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dhaval Vashi has taken over charge as Senior Vice President, Pharmaceuticals, and has become a member of the senior management team in place of Dr Chebiyyam. Vashi brings extensive experience to the role, having been associated with Atul Ltd since December 2022. He holds a postgraduate degree in science with a specialization in organic chemistry and a doctorate degree in synthetic organic chemistry, backed by approximately 22 years of experience in business development.

Simultaneously, Vinay Desai has been elevated to the position of Executive Vice President, Technology and Manufacturing, and has also joined the senior management team. Desai has been with the company since December 2022 and possesses about 35 years of experience in manufacturing and technology development. He holds a graduate degree in chemical engineering.

The disclosure confirmed that there are no specific relationships between the directors and the newly appointed senior management personnel that require reporting under the regulations. The appointments are aimed at strengthening the company's leadership in its pharmaceutical and manufacturing verticals.

Senior Management Appointments

Name Designation Department Experience Qualification
Dhaval Vashi Senior Vice President Pharmaceuticals 22 years in Business Development PhD in Synthetic Organic Chemistry, MSc in Organic Chemistry
Vinay Desai Executive Vice President Technology and Manufacturing 35 years in Manufacturing and Technology BE in Chemical Engineering

Historical Stock Returns for Atul

1 Day5 Days1 Month6 Months1 Year5 Years
-0.12%+0.33%-6.36%+6.19%-9.46%-33.36%

How will the new leadership's expertise influence Atul Ltd's strategic direction in the pharmaceutical sector?

What potential impact will these management changes have on the company's operational efficiency and innovation capabilities?

Could these appointments signal a shift in Atul Ltd's focus toward expanding its pharmaceutical or manufacturing verticals?

Atul Records ₹89.03 Crore Block Trade on BSE at ₹6082 Per Share

0 min read     Updated on 16 Jul 2026, 02:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

A block trade worth ₹89.03 crore was executed on BSE for approximately 146379 shares of Atul at a price of ₹6082 per share. Such large-scale transactions are typically associated with institutional market participants. The trade represents a significant single-session activity in the counter on the BSE.

powered bylight_fuzz_icon
45736551

*this image is generated using AI for illustrative purposes only.

A notable block trade was recorded on the BSE for atul , with approximately 146379 shares changing hands at a price of ₹6082 per share. The total value of the transaction stood at ₹89.03 crore, marking a significant single-transaction activity on the exchange.

Block Trade Details

The following table summarises the key parameters of the block trade executed on BSE:

Parameter: Details
Exchange: BSE
Number of Shares: ~146379
Trade Price: ₹6082 per share
Total Trade Value: ₹89.03 crore

Transaction Overview

Block trades are typically executed by institutional investors or large market participants and are carried out outside the regular order book to minimise market impact. The transaction in Atul at ₹6082 per share for approximately 146379 shares, aggregating to ₹89.03 crore, reflects substantial institutional interest in the stock on the BSE platform.

Historical Stock Returns for Atul

1 Day5 Days1 Month6 Months1 Year5 Years
-0.12%+0.33%-6.36%+6.19%-9.46%-33.36%

What are the potential reasons behind the institutional investor's decision to execute this block trade at the current price level?

How might this large transaction influence Atul's stock price and trading volume in the upcoming sessions?

Could this block trade signal a shift in market sentiment or upcoming strategic developments for Atul?

More News on Atul

1 Year Returns:-9.46%